Cargando…
New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA
In the last few years, much new information has been generated on the pathophysiology, possible therapeutic targets, and pharmacologic treatment of overactive bladder (OAB). Antimuscarinic drugs are still first-line pharmacologic treatment for OAB and often have good initial response rates, but adve...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634323/ https://www.ncbi.nlm.nih.gov/pubmed/23637536 http://dx.doi.org/10.2147/TCRM.S33052 |